Currently, there is no requirement for ICD-10-PCS training. Cancer registrars who don't maintain AHIMA credentials don't need ICD-10-specific credit hours, but it is strongly recommended that they familiarize themselves with the code set. Unfortunately, medical coder classes likely are more in-depth than what's necessary for registrars.
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
C78. 0 - Secondary malignant neoplasm of lung | ICD-10-CM.
Basic DifferencesLung NeoplasmTopography CodeBehavior CodeMetastatic neoplasm of the lung (such as metastatic seminoma from the testis)C34.9M-9061/6In situ neoplasm of the lung (such as squamous carcinoma in situ)C34.9M-8070/2Benign neoplasm of lung (such as adenoma)C34.9M-8140/02 more rows
Note: There are codes for cancer of C80. 1 Malignant (primary) neoplasm, unspecified and C79. 9 Secondary malignant neoplasm of unspecified site. A diagnosis of metastatic cancer not otherwise specified (NOS) is used most often when diagnostic tests were not completed.
Associated ICD-10-CM CodesMalignant neoplasm of bronchus and lungC34.90Malignant neoplasm of unspecified part of unspecified bronchus or lungC34.91Malignant neoplasm of unspecified part of right bronchus or lungC34.92Malignant neoplasm of unspecified part of left bronchus or lung18 more rows
If patient presents for treatment of secondary site ONLY, report the secondary code first, followed by primary malignancy. C79. 9 (Secondary malignant neoplasm of unspecified site) should be assigned when no site is identified for the secondary neoplasm.
ICD-10 Code for Secondary malignant neoplasm of unspecified site- C79. 9- Codify by AAPC.
Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
1. If the documentation states the cancer is a metastatic cancer, but does not state the site of the metastasis, the coder will assign a code for the primary cancer, followed by code C79. 9 secondary malignant neoplasm of unspecified site.
ICD-10-CM Code for Malignant (primary) neoplasm, unspecified C80. 1.
C34. 90 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C34. 90 became effective on October 1, 2021.
C79. 51 Secondary malignant neoplasm of bone - ICD-10-CM Diagnosis Codes.
ICD-10 code C34. 31 for Malignant neoplasm of lower lobe, right bronchus or lung is a medical classification as listed by WHO under the range - Malignant neoplasms .
Secondary malignant neoplasm of lung 1 C78.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 The 2021 edition of ICD-10-CM C78.0 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of C78.0 - other international versions of ICD-10 C78.0 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Cancer that has spread from the original (primary) tumor to the lung. The spread of cancer to the lung.
lymph node metastases ( C77.0) Secondary malignant neoplasm of respiratory and digestive organs. Clinical Information. Cancer that has spread from the original (primary) tumor to the lung. The spread of cancer to the lung. This may be from a primary lung cancer, or from a cancer at a distant site.
Lung cancer is the second most common cancer among both men and women in the United States, and is the leading cause of cancer death among both sexes. The number one risk factor for lung cancer is cigarette smoking. There are two main types of lung cancer .
Non-small cell cancer includes squamous cell carcinoma (also called epidermoid carcinoma), large cell carcinoma, and adenocarcinoma. Codes for lung cancer are categorized by morphology, site, and laterality (except C34.2 Malignant neoplasm of middle lobe, brounchus or lung because only the right lung has a middle lobe ).
Cancer of the lung, squamous cell, stage 1. Cancer of the lung, squamous cell, stage 2. Cancer of the lung, squamous cell, stage 3. Cancer of the lung, squamous cell, stage 4. Cancer, lung, non small cell. Eaton-lambert syndrome due to small cell carcinoma of lung. Eaton-lambert syndrome due to small cell lung cancer.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
When an encounter is for a pathological fracture due to a neoplasm, and the focus of treatment is the fracture, a code from subcategory M84.5, Pathological fracture in neoplastic disease, should be sequenced first, followed by the code for the neoplasm.
These guidelines, developed by the Centers for Medicare and Medicaid Services ( CMS) and the National Center for Health Statistics ( NCHS) are a set of rules developed to assist medical coders in assigning the appropriate codes. The guidelines are based on the coding and sequencing instructions from the Tabular List and the Alphabetic Index in ICD-10-CM.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Thyroid cancer metastatic to bone. Clinical Information. Cancer that has spread from the original (primary) tumor to the bone. The spread of a malignant neoplasm from a primary site to the skeletal system. The majority of metastatic neoplasms to the bone are carcinomas.
secondary carcinoid tumors ( C 7B.-) secondary neuroendocrine tumors ( C7B.-) Cancer that has spread from the original (primary) tumor to the bone.